conversion from semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Switching from Semaglutide to Tirzepatide:

One of the most important practical moves is documenting prior lifestyle work

As of April 2026, BPC-157 is not explicitly listed on the World Anti-Doping Agency (WADA) Prohibited List by name, though WADA's catch-all S0 category (non-approved substances) captures any compound without regulatory approval for human therapeutic use

Weight management requires health habits plus any additional treatment

R13.19: Other dysphagia

Jay looked at an $850 billion to $1 trillion prescription drug market growing at roughly 10% a year and thought: this is medieval

Foundayo's side effects are similar to those of GLP-1 shots According to Eli Lilly, based on clinical studies, the side effects of the Foundayo pill include nausea, constipation, diarrhea, vomiting, indigestion, stomach or abdominal pain, headache, swollen belly, tiredness, belching, heartburn, gas, and hair loss